Sage Journals: Discover world-class research

Open access

Research article

First published 2009-06

Infliximab in the Treatment of Anti-CTLA4 Antibody (Ipilimumab) Induced Immune-Related Colitis

David R. Minor, Kevin Chin, Mohammed Kashani-Sabet

Cancer Biotherapy and Radiopharmaceuticals

Open access

Review article

First published 2023

The introduction of LAG-3 checkpoint blockade in melanoma: immunotherapy landscape beyond PD-1 and CTLA-4 inhibition

Firas Y. Kreidieh, Hussein A. Tawbi

Therapeutic Advances in Medical Oncology

Retricted access

Research article

First published 2023-4

A comprehensive evaluation of the safety of ipilimumab,nivolumab and their combination therapy: A systematic review and network meta-analysis

Mahanjit Konwar, Debdipta Bose, Miteshkumar Maurya [...]

Journal of Oncology Pharmacy Practice

Open access

Research article

First published 2013-9

Ipilimumab for advanced melanoma: A pharmacologic perspective

Van Anh Trinh, Brenda Hagen

Journal of Oncology Pharmacy Practice

Open access

Review article

First published 2010-12

Releasing the Brake on the Immune System: Ipilimumab in Melanoma and Other Tumors

Ahmad Tarhini, Ernest Lo, David R. Minor

Cancer Biotherapy and Radiopharmaceuticals

Retricted access

Research article

First published 2011-4

Ipilimumab: A Novel Treatment for Metastatic Melanoma

Morgan E Culver, Mandy L Gatesman, Erin E Mancl [...]

Annals of Pharmacotherapy

Retricted access

Research article

First published 2014-2

Dose rounding of ipilimumab in adult metastatic melanoma patients results in significant cost savings *

Anthony Jarkowski, Jill S Nestico, Karen L Vona [...]

Journal of Oncology Pharmacy Practice

Retricted access

Research article

First published 2024

Real world comparison of immune-related adverse events with nivolumab-relatlimab versus ipilimumab-nivolumab in patients with advanced cutaneous melanoma

Brooke Kielkowski, Diana Mansour, Brooke Ebbert [...]

Journal of Oncology Pharmacy Practice

Retricted access

Case report

First published 2019-6

Acute autoimmune myocarditis and hepatitis due to ipilimumab monotherapy for malignant melanoma

Yazeed Samara, Chun Lai Yu, Constantin A Dasanu

Journal of Oncology Pharmacy Practice

Open access

Research article

First published 2023

Comparison of efficacy and tolerability of adjuvant therapy for resected high-risk stage III-IV cutaneous melanoma: a systemic review and Bayesian network meta-analysis

He Ba, Fangyuan Zhu, Xiaoze Zhang [...]

Therapeutic Advances in Medical Oncology

Search results